Global Nuclear Medicine Radioisotope Markets 2021-2027: Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Others – Technetium-99m (Tc-99m) to Account for $24.8 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nuclear Medicine Radioisotope – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Nuclear Medicine Radioisotope Market to Reach $36.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Nuclear Medicine Radioisotope estimated at US$17.1 Billion in the year 2020, is projected to reach a revised size of US$36.9 Billion by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027.

Technetium-99m (Tc-99m), one of the segments analyzed in the report, is projected to record a 12.3% CAGR and reach US$24.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Thallium-201 (Tl-201) segment is readjusted to a revised 10.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.1 Billion, While China is Forecast to Grow at 11.1% CAGR

The Nuclear Medicine Radioisotope market in the U.S. is estimated at US$5.1 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 9.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Iodine (I-123) Segment to Record 11.3% CAGR

In the global Iodine (I-123) segment, USA, Canada, Japan, China and Europe will drive the 11.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.5 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.3 Billion by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

• Bayer Healthcare AG
• Bracco Imaging SpA
• Cardinal Health, Inc.
• GE Healthcare
• Hologic, Inc.
• Lantheus Medical Imaging, Inc.
• Medtronic PLC
• NTP Radioisotopes SOC Ltd.
• Positron Corporation
• Siemens Healthineers

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• World Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
• World Historic Review for Nuclear Medicine Radioisotope by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
• World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
• World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Iodine (I-123) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Other Type of Radioisotopes by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Oncology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Cardiology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Lymphoma by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Thyroid by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
• World 15-Year Perspective for Neurology by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/df689t.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900